Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)

Fatma Abdelraouf; Egbert Smit; Baktiar Hasan; Jessica Menis; Sanjay Popat; Jan P. van Meerbeeck; Veerle F. Surmont; Paul Baas; Mary O'Brien

doi:10.1016/j.ejca.2015.10.016

Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)

Fatma Abdelraouf, Egbert Smit, Baktiar Hasan, Jessica Menis, Sanjay Popat, Jan P. van Meerbeeck, Veerle F. Surmont, Paul Baas, Mary O'Brien

Pulmonary medicine

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	35-39
Journal	European Journal of Cancer
Volume	54
DOIs	https://doi.org/10.1016/j.ejca.2015.10.016
Publication status	Published - Feb 2016

Access to Document

10.1016/j.ejca.2015.10.016

Cite this

Abdelraouf, F., Smit, E., Hasan, B., Menis, J., Popat, S., van Meerbeeck, J. P., Surmont, V. F., Baas, P., & O'Brien, M. (2016). Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061). European Journal of Cancer, 54, 35-39. https://doi.org/10.1016/j.ejca.2015.10.016

@article{cad0bb256bae470292835dda7a5b43ca,

title = "Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)",

keywords = "SCLC, Sunitinib, Tyrosine kinase inhibitor, Targeted therapy, Phase II study, Second-line treatment",

author = "Fatma Abdelraouf and Egbert Smit and Baktiar Hasan and Jessica Menis and Sanjay Popat and {van Meerbeeck}, {Jan P.} and Surmont, {Veerle F.} and Paul Baas and Mary O'Brien",

year = "2016",

month = feb,

doi = "10.1016/j.ejca.2015.10.016",

language = "English",

volume = "54",

pages = "35--39",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Pergamon",

}

Abdelraouf, F, Smit, E, Hasan, B, Menis, J, Popat, S, van Meerbeeck, JP, Surmont, VF, Baas, P & O'Brien, M 2016, 'Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)', European Journal of Cancer, vol. 54, pp. 35-39. https://doi.org/10.1016/j.ejca.2015.10.016

TY - JOUR

T1 - Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061)

AU - Abdelraouf, Fatma

AU - Smit, Egbert

AU - Hasan, Baktiar

AU - Menis, Jessica

AU - Popat, Sanjay

AU - van Meerbeeck, Jan P.

AU - Surmont, Veerle F.

AU - Baas, Paul

AU - O'Brien, Mary

PY - 2016/2

Y1 - 2016/2

KW - SCLC

KW - Sunitinib

KW - Tyrosine kinase inhibitor

KW - Targeted therapy

KW - Phase II study

KW - Second-line treatment

U2 - 10.1016/j.ejca.2015.10.016

DO - 10.1016/j.ejca.2015.10.016

M3 - Article

C2 - 26716400

SN - 0959-8049

VL - 54

SP - 35

EP - 39

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -